Literature DB >> 22482335

The effects of folic acid on markers of endothelial function in patients with type 1 diabetes mellitus.

Zahra Alian1, Mahin Hashemipour, Elham Hashemi Dehkordi, Silva Hovsepian, Massoud Amini, Mohammad Hassan Moadab, Shaghayegh Haghjooy Javanmard.   

Abstract

BACKGROUND: Endothelial dysfunction is considered as a fundamental and also preventable factor in the progression of vascular complications among type 1 diabetic patient. It occurs before the clinical manifestation of the mentioned complications. The aim of this study was to evaluate the effects of folic acid on endothelial function by measurements of adhesion molecules and von Willebrand factor (vWF) in patients with type 1 diabetes in Isfahan, Iran.
METHODS: This double blind, placebo-controlled crossover trial included type 1 diabetic patients aged 5-20 years old. Selected patients were randomized into two groups of A and B to receive folic acid 5 mg daily or placebo for 8 weeks. After a 2-week washout period, patients in the two groups were swapped to receive placebo or folic acid, respectively, for another 8 weeks. Blood and urine samples were taken to evaluate glycosylated hemoglobin (HbAlc), folic acid, vWF, intracellular adhesion molecule (ICAM), vascular cell adhesion molecule (VCAM), and microalbuminuria levels. Results of these measurements were compared in the two groups before and after folic acid and placebo administrations.
RESULTS: Fifty five type 1 diabetic patients aged 12.1 +/- 3.4 years with diabetes duration of 3.9 +/- 2.1 years were enrolled. Mean of folic acid level in the two studied groups was increased significantly (10.1 +/- 3.8 vs. 21.2 +/- 1.1 in group A and 15.5 +/- 1.9 vs. 19.9 +/- 2.8 in group B, p < 0.05). Mean of VCAM and microalbuminuria was decreased significantly after folic acid administration in the two groups (p < 0.05). Mean of HbA1c, ICAM and vWF did not significantly change after folic acid administration in the two groups (p > 0.05).
CONCLUSION: Folic acid administration decreased the level of endothelial dysfunction measured by adhesion molecules, especially VCAM and microalbuminuria. However, it did not significantly affect vWF. Further studies with larger sample size and long-term administration of folic acid are necessary for making precise decisions in this field. Key words: endothelial function, Diabetes Mellitus, folic acid.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22482335     DOI: 10.5455/medarh.2012.66.12-15

Source DB:  PubMed          Journal:  Med Arh        ISSN: 0350-199X


  5 in total

1.  Folic acid supplementation improves microvascular function in older adults through nitric oxide-dependent mechanisms.

Authors:  Anna E Stanhewicz; Lacy M Alexander; W Larry Kenney
Journal:  Clin Sci (Lond)       Date:  2015-07       Impact factor: 6.124

2.  Endothelial nitric oxide synthetase genetic variants, metabolic syndrome and endothelial function in schizophrenia.

Authors:  Kj Burghardt; Tb Grove; Vl Ellingrod
Journal:  J Psychopharmacol       Date:  2013-12-17       Impact factor: 4.153

3.  The effect of melatonin on endothelial dysfunction in patient undergoing coronary artery bypass grafting surgery.

Authors:  Shaghayegh Haghjooy Javanmard; Kiyan Heshmat-Ghahdarijani; Mohsen Mirmohammad-Sadeghi; Sayed Ali Sonbolestan; Amin Ziayi
Journal:  Adv Biomed Res       Date:  2016-11-28

4.  The Effect of Low-Carbohydrate Diet on Macrovascular and Microvascular Endothelial Function is Not Affected by the Provision of Caloric Restriction in Women with Obesity: A Randomized Study.

Authors:  Chueh-Lung Hwang; Christine Ranieri; Mary R Szczurek; Assem M Ellythy; Ahmed Elokda; Abeer M Mahmoud; Shane A Phillips
Journal:  Nutrients       Date:  2020-06-02       Impact factor: 5.717

5.  Identification of the Key Genes Involved in the Effect of Folic Acid on Endothelial Progenitor Cell Transcriptome of Patients with Type 1 Diabetes.

Authors:  Yi Lu; Qianhong Yang; Wei Hu; Jian Dong
Journal:  Comput Math Methods Med       Date:  2020-09-24       Impact factor: 2.238

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.